D. Brenner

J. Pandolfino, D. Carlson, M. Hinchcliff, 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

I. Andrulis, A. Mulligan, F. O'Malley, 2009, Anticancer research.

Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

B. Naliboff, E. Mayer, J. Lackner, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Reevaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data.

W. Chey, B. Lacy, D. Brenner, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

W. Chey, P. Schoenfeld, D. Brenner, 2007, The American Journal of Gastroenterology.

Possible Role of Meckel's Scan Fused with SPECT CT Imaging: Unraveling the Cause of Abdominal Pain and Obscure-Overt Gastrointestinal Bleeding

Richard K. J. Brown, D. Turgeon, D. Brenner, 2008, Case Reports in Gastroenterology.

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

W. Chey, M. Pimentel, B. Lacy, 2020, The American journal of gastroenterology.

(466) Analysis of opioid-mediated analgesia in studies with methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

L. Webster, A. Barrett, D. Brenner, 2015 .

Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study

B. Cash, C. Argoff, R. Blakesley, 2020, Pain.

Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review

D. Brenner, S. Rao, 2021, The American journal of gastroenterology.

AJG-20-3635 1156..1181

D. Brenner, S. Rao, 2022 .

Efficacy and Safety of Neostigmine and Decompressive Colonoscopy for Acute Colonic Pseudo-Obstruction: A Single-Center Analysis

E. Adler, D. Brenner, V. Venkatesh, 2021, Gastroenterology research.

T. Taft, D. Brenner, L. Guadagnoli, 2019, Quality of Life Research.

Validity of the ≥50% Response Threshold in Treatment With NASHA/Dx Injection Therapy for Fecal Incontinence

Jaime E. Sánchez, C. Paterson, A. Barrett, 2015, Clinical and Translational Gastroenterology.

Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation

S. Waldman, G. Sayuk, D. Brenner, 2022, The American journal of gastroenterology.

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Louis W C Liu, B. Cash, G. Sayuk, 2019, The American journal of gastroenterology.

Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome.

J. Lackner, L. Keefer, G. Gudleski, 2013, Behaviour research and therapy.

Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome.

J. Lackner, L. Keefer, G. Gudleski, 2013, Journal of Psychosomatic Research.

The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

J. Jaccard, J. Lackner, L. Keefer, 2012, Contemporary clinical trials.

Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials

R. Fogel, S. Dorn, L. Magnus, 2018, The American Journal of Gastroenterology.

Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology.

G. Kaplan, B. Spiegel, M. Crowell, 2020, The American journal of gastroenterology.

Naldemedine for the treatment of opioid-induced constipation in adults with chronic noncancer pain.

D. Brenner, Sarah Quinton, Joy J. Liu, 2020, Pain management.

Chronic Constipation.

D. Brenner, M. Shah, 2016, Gastroenterology clinics of North America.

Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

J. Jaccard, J. Lackner, L. Keefer, 2018, Gastroenterology.

Stimulant laxatives for the treatment of chronic constipation: is it time to change the paradigm?

D. Brenner, 2012, Gastroenterology.

Predicting prolonged length of stay in hospitalized children with respiratory syncytial virus

A. Metcalfe, D. Brenner, T. Pitt, 2022, Pediatric Research.

Mast cell activation in the systemic sclerosis esophagus

Tammara A. Wood, M. Whitfield, D. Carlson, 2020, Journal of scleroderma and related disorders.

Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis

N. Stambler, L. Webster, N. Slatkin, 2020, Pain medicine.

An Evidence-Based Review of Novel and Emerging Therapies for Constipation in Patients Taking Opioid Analgesics

W. Chey, D. Brenner, 2014 .

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

L. Webster, C. Paterson, E. Bortey, 2015, Journal of pain research.

(Can’t Get No) Patient Satisfaction: The Predictive Power of Demographic, GI, and Psychological Factors in IBS Patients

B. Quigley, J. Lackner, L. Keefer, 2017, Journal of clinical gastroenterology.

A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation

M. Camilleri, D. Brenner, C. Datto, 2019, The American journal of gastroenterology.

Don’t forget about constipation with opioid treatment of chronic non-cancer pain

A. Ford, P. Schoenfeld, D. Brenner, 2013, BMJ.

The First Case of Mumps-Associated Achalasia

D. Carlson, D. Brenner, L. Hillman, 2017, The American Journal of Gastroenterology.

Baseline Predictors of Discontinuation of Prescription Drug Therapy for IBS-C: Cohort Analysis at an Integrated Healthcare System

D. Brenner, V. Chen, E. Shah, 2021, Digestive Diseases and Sciences.

Evidence-based treatment recommendations for OTC management of chronic constipation

D. Brenner, S. Rao, 2022, Journal of the American Association of Nurse Practitioners.

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Louis W C Liu, B. Cash, G. Sayuk, 2019, American Journal of Gastroenterology.

Response to Black et al.

Louis W C Liu, B. Cash, G. Sayuk, 2020, The American journal of gastroenterology.

Spotlight on naldemedine in the treatment of opioid-induced constipation in adult patients with chronic noncancer pain: design, development, and place in therapy

D. Brenner, E. Stern, 2018, Journal of pain research.

Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.

P. Moayyedi, A. Zinsmeister, H. El‐Serag, 2012, Contemporary clinical trials.

Gender differences in irritable bowel syndrome: the interpersonal connection

M. Gurtman, J. Lackner, L. Keefer, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Efficacy and Safety of Eluxadoline in IBS-D Patients Who Report Inadequate Symptom Control With Prior Loperamide Use: A Phase 4, Multicenter, Multinational, Randomized, Placebo-controlled, Double-blinded Study (RELIEF): Presidential Poster Award

D. Brenner, Esther Jo, C. Gutman, 2018, American Journal of Gastroenterology.

Haloperidol Blocks Increased Locomotor Activity Elicited by Carbachol Infusion Into the Ventral Hippocampal Formation

M. Bardgett, D. Brenner, 1998, Pharmacology Biochemistry and Behavior.

Heterogeneity of primary and secondary peristalsis in systemic sclerosis: A new model of “scleroderma esophagus”

J. Pandolfino, H. Perlman, P. Kahrilas, 2021, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Opioid-Related Constipation.

D. Brenner, Joy J. Liu, 2022, Gastroenterology clinics of North America.

How to Manage Opioid-Related Constipation in Individuals With Chronic Nonmalignant Pain Syndromes.

B. Cash, D. Brenner, Meghan Barrett-Englert, 2020, The American journal of gastroenterology.

Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?

A. Shaukat, D. Brenner, 2019, The American journal of gastroenterology.

Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up

J. Jaccard, J. Lackner, L. Keefer, 2018, The American Journal of Gastroenterology.

P2-16 High burden of rheumatic diseases in a population based study from Lebanon

T. Spector, A. El-Sohemy, A. Badawi, 2011, Journal of Epidemiology & Community Health.

T. Taft, D. Brenner, L. Guadagnoli, 2017 .

302 Diagnostic Yield of Capsule Endoscopy vs. Colonoscopy in Patients With Melena and a Negative EGD

A. Singal, A. Waljee, D. Brenner, 2011 .

Up-front endoscopy maximizes cost-effectiveness and cost-satisfaction in uninvestigated dyspepsia.

W. Chey, A. Lembo, B. Moshiree, 2023, Clinical Gastroenterology and Hepatology.

Efficacy of Pharmacological Therapies for the Treatment of Opioid-Induced Constipation: Systematic Review and Meta-Analysis

A. Ford, P. Schoenfeld, D. Brenner, 2013, The American Journal of Gastroenterology.

J. Jaccard, J. Lackner, L. Keefer, 2012, Contemporary clinical trials.

Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials

W. Chey, Lin Chang, B. Lacy, 2021, The American journal of gastroenterology.

Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials

A. Ford, B. Lacy, C. Almansa, 2022, The American journal of gastroenterology.